Genomic Valley Biotech Ltd.

View in App
20.70 -1.05 ▼-4.8%

29 May 2023, 04:01:00 PM
Volume: 1,809

Company Profile

View details >>
Sector Agriculture Compare with Sector peers
Industry Agriculture Compare with Industry peers
Website http://www.genomicvalley.com
Market Cap 6.32 Cr.
Enterprise Value(EV) 6.31 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.61 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE - Trailing Twelve Months Ending 2022-12
Book Value / Share 8.33 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.48 Calculated using Price: 20.70
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.31 Cr. 3,054,500 Shares
FaceValue 10

Genomic Valley Biotech Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Genomic Valley Biotech Ltd. Performance

View details >>
1 Day
-4.83%
1 Week
-4.83%
1 Month
-4.83%
3 Month
-4.83%
6 Month
-22.18%
1 Year
-39.39%
2 Year
-12.29%
5 Year
10 Year

Genomic Valley Biotech Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.09 -0.17 -7.08 -1.51 0.76 5.01 5.83 -11.73 -0.25
Return on Capital Employed (%) 0.41 0.34 -5.99 -1.31 1.12 4.12 6.10 -5.14 0.93
Return on Assets (%) 0.05 -0.11 -4.61 -1.05 0.54 3.36 3.78 -7.19 -0.16

Genomic Valley Biotech Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 6 6 6 4 5 5 5 4 3 3
Non Curr. Liab. 1 1 1 1 1 2 2 2 1 1
Curr. Liab. 1 1 1 1 1 0 1 1 0 0
Minority Int.
Equity & Liab. 7 7 7 6 7 7 8 8 4 4
Non Curr. Assets 3 4 6 6 7 7 8 7 3 3
Curr. Assets 3 3 0 0 0 0 0 0 1 1
Misc. Exp. not W/O 1 1 1
Total Assets 7 7 7 6 7 7 8 8 4 4

Genomic Valley Biotech Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 0 0 0 0 1 1 1 0 0 2
Other Income 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 1 1 1 1 0 0 2
Total Expenditure 0 0 -1 -1 0 -1 0 0 0 -2
PBIDT 0 0 0 0 0 0 1 0 0 0
Interest 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0
Exceptional Items 0 0 0
PAT 0 0 0 0 0 0 -1 0 0
Adjusted EPS 0 0 -1 0 0 1 1 -2 0 -1

Genomic Valley Biotech Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 0 -1 0 1 -1 0 1 -2
Cash Fr. Inv. 0 0 -1 1 0 -1 0 0 -2 4
Cash Fr. Finan. 1 0 -2
Net Change 1 0 -1 0 0 0 0 0 0 0
Cash & Cash Eqvt 1 1 0 0 0 0 0 0 0

Genomic Valley Biotech Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 67.85 67.85 67.85 67.85 67.85 67.85 67.85 67.85 67.18
Public 32.15 32.15 32.15 32.15 32.15 32.15 32.15 32.15 32.82
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Genomic Valley Biotech Ltd. Announcements

View details >>
Mon, 29 May 2023
Audited Financial Results (Standalone) For The Quarter And Year Ended 31St March 2023
Audited Financial Results (Standalone) for the Quarter and Year ended 31st March 2023
Mon, 29 May 2023
Board Meeting Outcome for Outcomes Of Board Meeting And Audited Financial Results (Standalone) For The Quarter And Year Ended 31St March 2023
Outcomes of Board Meeting and Audited Financial Results (Standalone) for the Quarter and Year ended 31st March 2023
Mon, 29 May 2023
Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended 31.03.2023
Disclosure of Related Party Transactions under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the half year ended 31.03.2023

Genomic Valley Biotech Ltd. Technical Scans

View details >>
Mon, 29 May 2023
Close Crossing 52 Week Low Close Crossing 52 Week Low
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 6 Months High Decrease in 6 Months

Genomic Valley Biotech Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. 73,744.94 793.80 +0.5%
Shree Renuka Sugars Ltd. 9,335.56 43.86 +0.8%
E.I.D. - Parry (India) Ltd. 8,794.22 494.60 +0.2%
CCL Products (India) Ltd. 8,280.32 622.60 +0.9%
Balrampur Chini Mills Ltd. 7,942.87 393.90 +1.1%
Bombay Burmah Trading Corporation Ltd. 6,537.28 935.10 -1.1%
Triveni Engineering & Industries Ltd. 6,114.91 279.35 +1.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2023-03 61.26 793.80 +0.5%
Shree Renuka Sugars Ltd. Consolidated 2023-03 0.00 43.86 +0.8%
E.I.D. - Parry (India) Ltd. Consolidated 2022-12 8.20 494.60 +0.2%
CCL Products (India) Ltd. Consolidated 2023-03 30.80 622.60 +0.9%
Balrampur Chini Mills Ltd. Consolidated 2023-03 27.97 393.90 +1.1%
Bombay Burmah Trading Corporation Ltd. Consolidated 2023-03 0.00 935.10 -1.1%
Triveni Engineering & Industries Ltd. Consolidated 2023-03 3.41 279.35 +1.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2023-03 4.54 793.80 +0.5%
Shree Renuka Sugars Ltd. Consolidated 2023-03 -4.73 43.86 +0.8%
E.I.D. - Parry (India) Ltd. Consolidated 2022-12 1.41 494.60 +0.2%
CCL Products (India) Ltd. Consolidated 2023-03 5.59 622.60 +0.9%
Balrampur Chini Mills Ltd. Consolidated 2023-03 2.74 393.90 +1.1%
Bombay Burmah Trading Corporation Ltd. Consolidated 2023-03 1.62 935.10 -1.1%
Triveni Engineering & Industries Ltd. Consolidated 2023-03 2.29 279.35 +1.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Tata Consumer Products Ltd. Consolidated 2023-03 0.07 793.80 +0.5%
Shree Renuka Sugars Ltd. Consolidated 2022-03 -2.94 43.86 +0.8%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 0.15 494.60 +0.2%
CCL Products (India) Ltd. Consolidated 2022-03 0.52 622.60 +0.9%
Balrampur Chini Mills Ltd. Consolidated 2022-03 0.44 393.90 +1.1%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 1.07 935.10 -1.1%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 0.82 279.35 +1.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2023-03 8.58 793.80 +0.5%
Shree Renuka Sugars Ltd. Consolidated 2022-03 0.00 43.86 +0.8%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 31.83 494.60 +0.2%
CCL Products (India) Ltd. Consolidated 2022-03 17.53 622.60 +0.9%
Balrampur Chini Mills Ltd. Consolidated 2022-03 16.80 393.90 +1.1%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 26.01 935.10 -1.1%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 21.07 279.35 +1.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2023-03 8.58 793.80 +0.5%
Shree Renuka Sugars Ltd. Consolidated 2022-03 0.00 43.86 +0.8%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 31.83 494.60 +0.2%
CCL Products (India) Ltd. Consolidated 2022-03 17.53 622.60 +0.9%
Balrampur Chini Mills Ltd. Consolidated 2022-03 16.80 393.90 +1.1%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 26.01 935.10 -1.1%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 21.07 279.35 +1.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2023-03 13,783.16 793.80 +0.5%
Shree Renuka Sugars Ltd. Consolidated 2022-03 6,432.63 43.86 +0.8%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 23,531.50 494.60 +0.2%
CCL Products (India) Ltd. Consolidated 2022-03 1,462.03 622.60 +0.9%
Balrampur Chini Mills Ltd. Consolidated 2022-03 4,846.03 393.90 +1.1%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 14,544.29 935.10 -1.1%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 4,290.94 279.35 +1.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2023-03 1,346.52 793.80 +0.5%
Shree Renuka Sugars Ltd. Consolidated 2022-03 -136.72 43.86 +0.8%
E.I.D. - Parry (India) Ltd. Consolidated 2022-03 1,573.70 494.60 +0.2%
CCL Products (India) Ltd. Consolidated 2022-03 204.35 622.60 +0.9%
Balrampur Chini Mills Ltd. Consolidated 2022-03 452.69 393.90 +1.1%
Bombay Burmah Trading Corporation Ltd. Consolidated 2022-03 1,424.99 935.10 -1.1%
Triveni Engineering & Industries Ltd. Consolidated 2022-03 364.91 279.35 +1.9%

Genomic Valley Biotech Ltd. FAQ's

What is Genomic Valley share price?
Can I buy Genomic Valley shares now?
What is the Market Cap of Genomic Valley?
What are the key metrics to analyse Genomic Valley?
What is the 52 Week High and Low of Genomic Valley?
What is the trend of Genomic Valley share price?